Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by canadapieton Jan 28, 2021 2:40am
153 Views
Post# 32406912

RE:Dumping 20M shares and keeping 10M warrants @$3.18

RE:Dumping 20M shares and keeping 10M warrants @$3.18JayjayUSA12007 - (1/28/2021 2:16:59 AM) 
Dumping 20M shares and keeping 10M warrants @$3.18
Quote:"...the Company issued 16,727,900 units of the Company (the “Units”) at a price of US$2.75 per Unit (equivalent to approximately C$3.51 per Unit) (the “Offering Price”) for aggregate gross proceeds to the Company of US$46,001,725 (equivalent to approximately C$58,714,929), including the full exercise of the over-allotment option to purchase an additional 2,181,900 Units at the Offering Price.

Each Unit is comprised of one common share of the Company (a “Common Share”) and one-half of one Common Share purchase warrant of the Company (each whole warrant, a “Warrant”). Each Warrant entitles the holder thereof to purchase one Common Share at an exercise price of US$3.18 (equivalent to approximately C$4.06) at any time until January 19, 2024."

These funds bought 16,727,900 + 2,181,900= 19M shares @ $2.75/shares and acquired 9.5M warrants @ $3.18
Let's say they will dump 19M shares on the market  at average price of $2.20/shares and keep 9.5M warrants. It would be equivalent to buying 9.5M Jan 2024 call options at strike price of $3.18 for $0.98/shares ($3.18 - $2.20). They will make unlimited gain when PPS goes up from now until 2024, but the most that they could lose would be just $0.98/share.
Whichever funds made this deal are genius and conversely, whoever in Thera negotiated this deal is an idiot !
This deal shows either the level of desperation or the depth of idiocy at Thera. Which one was it ?




Exactly!!!!!!!! 
What i said earlier! No company is doing such a deal lately! Even obscure firms get 100 M of 
dollars these days in offerings WITHOUT WARRANTS!!!! 
THTX has done it before with the convertable bonds!!! 
Doing such an offer is killing the existing shareholders and they new it! 
Scam, in the US there would be a class action! 

<< Previous
Bullboard Posts
Next >>